Efficacy of Second-line Tyrosine Kinase Inhibitors in the Treatment of Metastatic Advanced Non-small-cell Lung Cancer Harboring Exon 19 and 21 EGFR Mutations
Keyword(s):
2011 ◽
Vol 11
(10)
◽
pp. 1587-1597
◽
Keyword(s):